AngioDynamics, Inc. ANGO
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.20% | 9.46% | 10.73% | 7.26% | 2.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.20% | 9.46% | 10.73% | 7.26% | 2.73% |
| Cost of Revenue | 5.53% | 7.78% | 10.88% | 3.03% | -2.46% |
| Gross Profit | 10.46% | 10.90% | 10.61% | 11.07% | 7.58% |
| SG&A Expenses | 6.52% | 8.25% | 6.21% | 4.70% | 4.98% |
| Depreciation & Amortization | 3.43% | 3.53% | 2.41% | -4.65% | -13.27% |
| Other Operating Expenses | 127.99% | 127.99% | -536.28% | -536.28% | -536.28% |
| Total Operating Expenses | 7.05% | 8.41% | 7.76% | 3.05% | -0.67% |
| Operating Income | 8.20% | 4.68% | 24.25% | 35.53% | 30.91% |
| Income Before Tax | -1.72% | -6.66% | 25.41% | 88.33% | 86.53% |
| Income Tax Expenses | 266.36% | 1,233.33% | 101.79% | 99.98% | -102.77% |
| Earnings from Continuing Operations | -2.61% | -8.09% | 24.17% | 87.67% | 86.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.61% | -8.09% | 24.17% | 87.67% | 86.79% |
| EBIT | 8.20% | 4.68% | 24.25% | 35.53% | 30.91% |
| EBITDA | 204.37% | 110.09% | 87.98% | 104.78% | 84.18% |
| EPS Basic | -0.88% | -6.34% | 25.37% | 87.93% | 87.03% |
| Normalized Basic EPS | 3.91% | -5.10% | 21.23% | 49.94% | 45.56% |
| EPS Diluted | -0.41% | -5.73% | 25.55% | 87.86% | 86.97% |
| Normalized Diluted EPS | 3.91% | -5.10% | 21.23% | 49.94% | 45.56% |
| Average Basic Shares Outstanding | 1.78% | 1.59% | 1.50% | 1.43% | 1.49% |
| Average Diluted Shares Outstanding | 1.78% | 1.59% | 1.50% | 1.43% | 1.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |